INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $300,643 | -35.1% | 9,508 | -16.3% | 0.02% | -35.7% |
Q2 2023 | $463,221 | -8.8% | 11,359 | -16.6% | 0.03% | -17.6% |
Q1 2023 | $507,842 | +59.7% | 13,626 | +49.5% | 0.03% | +47.8% |
Q4 2022 | $318,022 | -56.7% | 9,115 | -30.5% | 0.02% | -58.2% |
Q3 2022 | $734,000 | -3.7% | 13,112 | -10.9% | 0.06% | 0.0% |
Q2 2022 | $762,000 | -26.9% | 14,717 | +2.5% | 0.06% | -6.8% |
Q1 2022 | $1,043,000 | +13.0% | 14,355 | +83.9% | 0.06% | +13.5% |
Q4 2021 | $923,000 | -31.1% | 7,805 | -21.8% | 0.05% | -40.9% |
Q3 2021 | $1,339,000 | -28.2% | 9,984 | -13.3% | 0.09% | -32.3% |
Q2 2021 | $1,865,000 | +122.6% | 11,521 | +10.3% | 0.13% | +97.0% |
Q1 2021 | $838,000 | +140.8% | 10,441 | +63.1% | 0.07% | +106.2% |
Q4 2020 | $348,000 | – | 6,403 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |